In the human HCC xenograft tumor models, including subcutaneous and orthotopic tumor xenografts, DLK1 knockdown can significantly suppress tumor growth (Figures 2A–2C and 3A–3D; Figure S2A–S2C). This evidence concerns the gene DLK1 and neoplasm.